Treatments - Medika Life

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Jackie Kennedy and Jane Fonda — Same Diagnosis, Different Decades and Treatments

Ivermectin is Dead and Buried Despite NIH Website Misstep and Twitter Buzz

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Heading Off Heartburn

LATEST

TRENDING

Jackie Kennedy and Jane Fonda — Same Diagnosis, Different Decades and Treatments

Ten Facts You Didn’t Know About Moderna and Their mRNA Vaccine

Ivermectin is Dead and Buried Despite NIH Website Misstep and Twitter Buzz

Killing The Coronavirus. A New Treatment Shows 99.9 Percent Efficacy

Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

Is mRNA Technology the New Penicillin?

Artificial Intelligence Company Helps IVF Patients Get Pregnant

FDA Approval of New Drug for Alzheimer’s Offers Hope

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

The Fluoroscope Serves as a Warning for New Medical Technology

Ten Facts You Didn’t Know About Moderna and Their mRNA Vaccine

Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids

FDA Approval of New Drug for Alzheimer’s Offers Hope

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories